|
|
Previous Article | Table of Contents | Next Article 
Retinoic acid and granulocyte colony-stimulating factor synergistically
induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells
M Gianni, M Terao, S Zanotta, T Barbui, A Rambaldi and E Garattini
Unita di Biologia Molecolare, Centro Catullo e Daniela Borgomainerio,
Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
In this report we show a strong synergistic interaction between granulocyte
colony-stimulating factor (G-CSF) and all-trans retinoic acid (ATRA) on the
expression of leukocyte alkaline phosphatase (LAP) in freshly isolated
acute promyelocytic leukemia (APL) blasts as well as in NB40 and HL-60 cell
lines. The strong synergism observed in these cell types was not evident in
two acute leukemia cell lines (K562 and GF-D8), in normal granulocytes, and
in monocytes. In freshly isolated leukocytes derived from chronic
myelogenous leukemia (CML), in the stable phase of the disease, a weaker
interaction between ATRA and G- CSF was documented. The cross-talk between
the cytokine and the retinoid was studied in detail in NB4, an immortalized
APL leukemia cell line, retaining the 15-17 chromosomal translocation
involving the retinoic acid receptor type alpha. The treatment of NB4 cells
with G- CSF alone or ATRA alone leads to no increase and to minor induction
in LAP activity, respectively. If the cells are treated with the two
compounds simultaneously, a dramatic elevation of LAP is observed after 4
days. The synergism between G-CSF and ATRA is evident at concentrations of
the retinoid between 10(-7) and 10(-5) mol/L and at concentrations of the
cytokine between 1 and 10 ng/mL. The simultaneous presence of the two
compounds is necessary to obtain maximal increase of LAP activity and the
effect is cell density-dependent. Synergism is specific for G-CSF, and it
is not observed with other cytokines and functional inducers of the
granulocyte. The augmentation of LAP activity is the consequence of an
increased transcriptional rate of the liver/bone/kidney-type (L/B/K-type)
alkaline phosphatase gene, as determined by Northern blotting and nuclear
run-on analysis using specific cDNA probes. Only one of the two possible
alternatively spliced forms of L/B/K-type alkaline phosphatase transcript
is detected in NB4 cells after stimulation with G-CSF and ATRA. This mRNA
form, which is the one observed in normal polymorphonuclear leukocytes,
contains the most upstream leader exon. In NB4 cells, ATRA induces G- CSF,
alpha, and beta retinoic acid receptor transcripts, whereas G-CSF has minor
effects on the expression of these mRNAs.
Volume 83,
Issue 7,
pp. 1909-1921,
04/01/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Parrella, M. Gianni', V. Cecconi, E. Nigro, M. M. Barzago, A. Rambaldi, C. Rochette-Egly, M. Terao, and E. Garattini
Phosphodiesterase IV Inhibition by Piclamilast Potentiates the Cytodifferentiating Action of Retinoids in Myeloid Leukemia Cells: CROSS-TALK BETWEEN THE cAMP AND THE RETINOIC ACID SIGNALING PATHWAYS
J. Biol. Chem.,
October 1, 2004;
279(40):
42026 - 42040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Maun, P. Gaines, A. Khanna-Gupta, T. Zibello, L. Enriquez, L. Goldberg, and N. Berliner
G-CSF signaling can differentiate promyelocytes expressing a defective retinoic acid receptor: evidence for divergent pathways regulating neutrophil differentiation
Blood,
March 1, 2004;
103(5):
1693 - 1701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Garattini, E. Parrella, L. Diomede, M. Gianni', Y. Kalac, L. Merlini, D. Simoni, R. Zanier, F. F. Ferrara, I. Chiarucci, et al.
ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis
Blood,
January 1, 2004;
103(1):
194 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Witcher, D. T. Ross, C. Rousseau, L. Deluca, and W. H. Miller Jr
Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells
Blood,
July 1, 2003;
102(1):
237 - 245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pisano, P. Kollar, M. Gianni, Y. Kalac, V. Giordano, F. F. Ferrara, R. Tancredi, A. Devoto, A. Rinaldi, A. Rambaldi, et al.
Bis-indols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells
Blood,
November 15, 2002;
100(10):
3719 - 3730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Drouin, R. Favier, J.-M. Masse, N. Debili, A. Schmitt, C. Elbim, J. Guichard, M. Adam, M.-A. Gougerot-Pocidalo, and E. M. Cramer
Newly recognized cellular abnormalities in the gray platelet syndrome
Blood,
September 1, 2001;
98(5):
1382 - 1391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gianni', Y. Kalac, I. Ponzanelli, A. Rambaldi, M. Terao, and E. Garattini
Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RAR{alpha} and PML-RAR{alpha}
Blood,
May 15, 2001;
97(10):
3234 - 3243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Finch, J. Li, T-C. Chou, and A. C. Sartorelli
Maintenance of retinoic acid receptor alpha pools by granulocyte colony-stimulating factor and lithium chloride in all-trans retinoic acid-treated WEHI-3B leukemia cells: relevance to the synergistic induction of terminal differentiation
Blood,
September 15, 2000;
96(6):
2262 - 2268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Melnick and J. D. Licht
Deconstructing a Disease: RAR{alpha}, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia
Blood,
May 15, 1999;
93(10):
3167 - 3215.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mologni, I. Ponzanelli, F. Bresciani, G. Sardiello, D. Bergamaschi, M. Gianni, U. Reichert, A. Rambaldi, M. Terao, and E. Garattini
The Novel Synthetic Retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid (CD437) Causes Apoptosis in Acute Promyelocytic Leukemia Cells Through Rapid Activation of Caspases
Blood,
February 1, 1999;
93(3):
1045 - 1061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Monczak, M. Trudel, W. W. Lamph, and W. H. Miller Jr
Induction of Apoptosis Without Differentiation by Retinoic Acid in PLB-985 Cells Requires the Activation of Both RAR and RXR
Blood,
November 1, 1997;
90(9):
3345 - 3355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Miyauchi, K. Ohyashiki, Y. Inatomi, and K. Toyama
Neutrophil Secondary-Granule Deficiency as a Hallmark of All-Trans Retinoic Acid-Induced Differentiation of Acute Promyelocytic Leukemia Cells
Blood,
July 15, 1997;
90(2):
803 - 813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gianni, M. Terao, I. Fortino, M. LiCalzi, V. Viggiano, T. Barbui, A. Rambaldi, and E. Garattini
Stat1 Is Induced and Activated by All-Trans Retinoic Acid in Acute Promyelocytic Leukemia Cells
Blood,
February 1, 1997;
89(3):
1001 - 1012.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |